XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.3
EARNINGS (LOSS) PER SHARE
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE EARNINGS (LOSS) PER SHARE
The following table presents earnings (loss) per share for the three and nine months ended September 30, 2025 and 2024:
Three Months Ended September 30,Nine Months Ended September 30,
(shares presented in the table are in thousands)2025202420252024
Net income (loss)$21,865 $(7,903)$59,364 $8,366 
Weighted average shares outstanding - basic19,224 19,088 19,185 13,298 
Dilutive effect of share-based compensation140 138 160 143 
Weighted average shares outstanding - diluted19,364 19,226 19,345 13,441 
Per share information:
Basic earnings (loss) per share$1.14 $(0.41)$3.09 $0.63 
Diluted earnings (loss) per share1.13 (0.41)3.07 0.62 
For the three and nine months ended September 30, 2025, the total average shares of the outstanding antidilutive restricted stock grants were 1,600 and 73,000 shares, respectively, compared to 268,000 and 131,000 shares for the three and nine months ended September 30, 2024, respectively. For the three and nine months ended September 30, 2025, the total average shares of the exercisable antidilutive stock options outstanding were zero and 1,900 shares, respectively. For the three and nine months ended September 30, 2024, there were no antidilutive exercisable stock options. Antidilutive shares are excluded from the computation of earnings per share as the grant price exceeded the average market price. The dilutive effect of share-based compensation in each period above relates to restricted stock awards and vested stock options.